Correlation between osteoporosis and cardiovascular disease

Delia Sprini, Giovam Battista Rini, Laura Di Stefano, Luisella Cianferotti, Nicola Napoli

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Several evidences have shown in the last years a possible correlation between cardiovascular diseases and osteoporosis. Patients affected with osteoporosis, for example, have a higher risk of cardiovascular diseases than subjects with normal bone mass. However, the heterogeneous approaches and the different populations that have been studied so far have limited the strength of the findings. Studies conducted in animal models show that vascular calcification is a very complex mechanism that involves similar pathways described in the normal bone calcification. Proteins like BMP, osteopontin, osteoprotegerin play an important role at the bone level but are also highly expressed in the calcified vascular tissue. In particular, it seems that the OPG protect from vascular calcification and elevated levels have been found in patients with CVD. Other factors like oxidative stress, inflammation, free radicals, lipids metabolism are involved in this complex scenario. It is not a case that medications used for treating osteoporosis also inhibit the atherosclerotic process, acting on blood pressure and ventricular hypertrophy. Given the limited amount of available data, further studies are needed to elucidate the underlying mechanisms between osteoporosis and cardiovascular disease which may be important in the future also for preventive and therapeutic approaches of both conditions.

Original languageEnglish
Pages (from-to)117-119
Number of pages3
JournalClinical Cases in Mineral and Bone Metabolism
Volume11
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Osteoporosis
Cardiovascular Diseases
Vascular Calcification
Bone and Bones
Osteoprotegerin
Osteopontin
Lipid Metabolism
Hypertrophy
Free Radicals
Blood Vessels
Oxidative Stress
Animal Models
Blood Pressure
Inflammation
Population
Proteins
Therapeutics

Keywords

  • Cardiovascular disease
  • Osteoporosis
  • Vascular calcification

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Sprini, D., Rini, G. B., Di Stefano, L., Cianferotti, L., & Napoli, N. (2014). Correlation between osteoporosis and cardiovascular disease. Clinical Cases in Mineral and Bone Metabolism, 11(2), 117-119. https://doi.org/10.11138/ccmbm/2014.11.2.117

Correlation between osteoporosis and cardiovascular disease. / Sprini, Delia; Rini, Giovam Battista; Di Stefano, Laura; Cianferotti, Luisella; Napoli, Nicola.

In: Clinical Cases in Mineral and Bone Metabolism, Vol. 11, No. 2, 2014, p. 117-119.

Research output: Contribution to journalArticle

Sprini, D, Rini, GB, Di Stefano, L, Cianferotti, L & Napoli, N 2014, 'Correlation between osteoporosis and cardiovascular disease', Clinical Cases in Mineral and Bone Metabolism, vol. 11, no. 2, pp. 117-119. https://doi.org/10.11138/ccmbm/2014.11.2.117
Sprini, Delia ; Rini, Giovam Battista ; Di Stefano, Laura ; Cianferotti, Luisella ; Napoli, Nicola. / Correlation between osteoporosis and cardiovascular disease. In: Clinical Cases in Mineral and Bone Metabolism. 2014 ; Vol. 11, No. 2. pp. 117-119.
@article{f3d60e4a4d88405b85b39c688a900b60,
title = "Correlation between osteoporosis and cardiovascular disease",
abstract = "Several evidences have shown in the last years a possible correlation between cardiovascular diseases and osteoporosis. Patients affected with osteoporosis, for example, have a higher risk of cardiovascular diseases than subjects with normal bone mass. However, the heterogeneous approaches and the different populations that have been studied so far have limited the strength of the findings. Studies conducted in animal models show that vascular calcification is a very complex mechanism that involves similar pathways described in the normal bone calcification. Proteins like BMP, osteopontin, osteoprotegerin play an important role at the bone level but are also highly expressed in the calcified vascular tissue. In particular, it seems that the OPG protect from vascular calcification and elevated levels have been found in patients with CVD. Other factors like oxidative stress, inflammation, free radicals, lipids metabolism are involved in this complex scenario. It is not a case that medications used for treating osteoporosis also inhibit the atherosclerotic process, acting on blood pressure and ventricular hypertrophy. Given the limited amount of available data, further studies are needed to elucidate the underlying mechanisms between osteoporosis and cardiovascular disease which may be important in the future also for preventive and therapeutic approaches of both conditions.",
keywords = "Cardiovascular disease, Osteoporosis, Vascular calcification",
author = "Delia Sprini and Rini, {Giovam Battista} and {Di Stefano}, Laura and Luisella Cianferotti and Nicola Napoli",
year = "2014",
doi = "10.11138/ccmbm/2014.11.2.117",
language = "English",
volume = "11",
pages = "117--119",
journal = "Clinical Cases in Mineral and Bone Metabolism",
issn = "1724-8914",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "2",

}

TY - JOUR

T1 - Correlation between osteoporosis and cardiovascular disease

AU - Sprini, Delia

AU - Rini, Giovam Battista

AU - Di Stefano, Laura

AU - Cianferotti, Luisella

AU - Napoli, Nicola

PY - 2014

Y1 - 2014

N2 - Several evidences have shown in the last years a possible correlation between cardiovascular diseases and osteoporosis. Patients affected with osteoporosis, for example, have a higher risk of cardiovascular diseases than subjects with normal bone mass. However, the heterogeneous approaches and the different populations that have been studied so far have limited the strength of the findings. Studies conducted in animal models show that vascular calcification is a very complex mechanism that involves similar pathways described in the normal bone calcification. Proteins like BMP, osteopontin, osteoprotegerin play an important role at the bone level but are also highly expressed in the calcified vascular tissue. In particular, it seems that the OPG protect from vascular calcification and elevated levels have been found in patients with CVD. Other factors like oxidative stress, inflammation, free radicals, lipids metabolism are involved in this complex scenario. It is not a case that medications used for treating osteoporosis also inhibit the atherosclerotic process, acting on blood pressure and ventricular hypertrophy. Given the limited amount of available data, further studies are needed to elucidate the underlying mechanisms between osteoporosis and cardiovascular disease which may be important in the future also for preventive and therapeutic approaches of both conditions.

AB - Several evidences have shown in the last years a possible correlation between cardiovascular diseases and osteoporosis. Patients affected with osteoporosis, for example, have a higher risk of cardiovascular diseases than subjects with normal bone mass. However, the heterogeneous approaches and the different populations that have been studied so far have limited the strength of the findings. Studies conducted in animal models show that vascular calcification is a very complex mechanism that involves similar pathways described in the normal bone calcification. Proteins like BMP, osteopontin, osteoprotegerin play an important role at the bone level but are also highly expressed in the calcified vascular tissue. In particular, it seems that the OPG protect from vascular calcification and elevated levels have been found in patients with CVD. Other factors like oxidative stress, inflammation, free radicals, lipids metabolism are involved in this complex scenario. It is not a case that medications used for treating osteoporosis also inhibit the atherosclerotic process, acting on blood pressure and ventricular hypertrophy. Given the limited amount of available data, further studies are needed to elucidate the underlying mechanisms between osteoporosis and cardiovascular disease which may be important in the future also for preventive and therapeutic approaches of both conditions.

KW - Cardiovascular disease

KW - Osteoporosis

KW - Vascular calcification

UR - http://www.scopus.com/inward/record.url?scp=84940275547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940275547&partnerID=8YFLogxK

U2 - 10.11138/ccmbm/2014.11.2.117

DO - 10.11138/ccmbm/2014.11.2.117

M3 - Article

VL - 11

SP - 117

EP - 119

JO - Clinical Cases in Mineral and Bone Metabolism

JF - Clinical Cases in Mineral and Bone Metabolism

SN - 1724-8914

IS - 2

ER -